1-3 of 3
Edward Anthony Faber, Jr., DO, MS
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase 1 Study of Tabalumab, a Human Anti-BAFF Antibody and Bortezomib in Patients with Previously-Treated Multiple Myeloma

Noopur Raje, MD, Edward Anthony Faber, Jr., DO, MS, Paul G. Richardson, MD, Gary J. Schiller, MD, Raymond J. Hohl, MD, PhD, Adam D. Cohen, MD, Andres Forero, MD, Susan P. Carpenter, PhD, Damien Cronier, PhD, Christopher Kaiser, PhD, James E. Wooldridge, MD, Kenneth C. Anderson, MD
Journal: Blood
Blood (2012) 120 (21): 447.
https://doi.org/10.1182/blood.V120.21.447.447
Published: 2012
Journal Articles

Trend Analysis of 5-Year All-Cause Mortality After Autologous Stem Cell Transplantation in Patients with Lymphoma and Multiple Myeloma

Mojtaba Akhtari, MD, James O. Armitage, Philip Bierman, MD, R. Gregory Bociek, MD, Edward Anthony Faber, Jr., DO, MS, Lori Maness, M.D., Julie M Vose, MD, Fausto R. Loberiza, Jr., MD, MS
Journal: Blood
Blood (2011) 118 (21): 842.
https://doi.org/10.1182/blood.V118.21.842.842
Published: 2011
Journal Articles

A Retrospective Analysis Comparing BEAM Versus Melphalan Prior to First Autologous Peripheral Blood Hematopoietic Stem Cell Transplant in Newly Diagnosed Multiple Myeloma Patients

Edward Anthony Faber, Jr., DO, MS, Fausto R. Loberiza, Jr., MD, MS, Mojtaba Akhtari, Philip Bierman, MD, R. Gregory Bociek, MD, Lori Maness, M.D., Julie M Vose, MD
Journal: Blood
Blood (2011) 118 (21): 2040.
https://doi.org/10.1182/blood.V118.21.2040.2040
Published: 2011